235 related articles for article (PubMed ID: 19742316)
1. LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation.
Zhou L; Takayama Y; Boucher P; Tallquist MD; Herz J
PLoS One; 2009 Sep; 4(9):e6922. PubMed ID: 19742316
[TBL] [Abstract][Full Text] [Related]
2. Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta).
Takayama Y; May P; Anderson RG; Herz J
J Biol Chem; 2005 May; 280(18):18504-10. PubMed ID: 15753096
[TBL] [Abstract][Full Text] [Related]
3. The LDL receptor-related protein 1 (LRP1) regulates the PDGF signaling pathway by binding the protein phosphatase SHP-2 and modulating SHP-2- mediated PDGF signaling events.
Craig J; Mikhailenko I; Noyes N; Migliorini M; Strickland DK
PLoS One; 2013; 8(7):e70432. PubMed ID: 23922991
[TBL] [Abstract][Full Text] [Related]
4. LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome.
Boucher P; Li WP; Matz RL; Takayama Y; Auwerx J; Anderson RG; Herz J
PLoS One; 2007 May; 2(5):e448. PubMed ID: 17505534
[TBL] [Abstract][Full Text] [Related]
5. LRP1 protects the vasculature by regulating levels of connective tissue growth factor and HtrA1.
Muratoglu SC; Belgrave S; Hampton B; Migliorini M; Coksaygan T; Chen L; Mikhailenko I; Strickland DK
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2137-46. PubMed ID: 23868935
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the platelet-derived growth factor receptor-beta by G protein-coupled receptor kinase-5 in vascular smooth muscle cells involves the phosphatase Shp2.
Wu JH; Goswami R; Cai X; Exum ST; Huang X; Zhang L; Brian L; Premont RT; Peppel K; Freedman NJ
J Biol Chem; 2006 Dec; 281(49):37758-72. PubMed ID: 17018529
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations.
Mellgren AM; Smith CL; Olsen GS; Eskiocak B; Zhou B; Kazi MN; Ruiz FR; Pu WT; Tallquist MD
Circ Res; 2008 Dec; 103(12):1393-401. PubMed ID: 18948621
[TBL] [Abstract][Full Text] [Related]
8. LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Regulates Smooth Muscle Contractility by Modulating Ca
Au DT; Ying Z; Hernández-Ochoa EO; Fondrie WE; Hampton B; Migliorini M; Galisteo R; Schneider MF; Daugherty A; Rateri DL; Strickland DK; Muratoglu SC
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2651-2664. PubMed ID: 30354243
[TBL] [Abstract][Full Text] [Related]
9. Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-beta in endosomes and regulates activation of the MAPK pathway.
Muratoglu SC; Mikhailenko I; Newton C; Migliorini M; Strickland DK
J Biol Chem; 2010 May; 285(19):14308-17. PubMed ID: 20220145
[TBL] [Abstract][Full Text] [Related]
10. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C
Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528
[TBL] [Abstract][Full Text] [Related]
11. The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells.
Dissmore T; Seye CI; Medeiros DM; Weisman GA; Bradford B; Mamedova L
Atherosclerosis; 2016 Sep; 252():128-135. PubMed ID: 27522265
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis.
Gordts PL; Reekmans S; Lauwers A; Van Dongen A; Verbeek L; Roebroek AJ
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1258-64. PubMed ID: 19667105
[TBL] [Abstract][Full Text] [Related]
13. Smooth muscle LDL receptor-related protein-1 inactivation reduces vascular reactivity and promotes injury-induced neointima formation.
Basford JE; Moore ZW; Zhou L; Herz J; Hui DY
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1772-8. PubMed ID: 19729608
[TBL] [Abstract][Full Text] [Related]
14. MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing.
Lehti K; Rose NF; Valavaara S; Weiss SJ; Keski-Oja J
J Cell Sci; 2009 Jan; 122(Pt 1):126-35. PubMed ID: 19066283
[TBL] [Abstract][Full Text] [Related]
15. LRP: role in vascular wall integrity and protection from atherosclerosis.
Boucher P; Gotthardt M; Li WP; Anderson RG; Herz J
Science; 2003 Apr; 300(5617):329-32. PubMed ID: 12690199
[TBL] [Abstract][Full Text] [Related]
16. Differential signaling by adaptor molecules LRP1 and ShcA regulates adipogenesis by the insulin-like growth factor-1 receptor.
Woldt E; Matz RL; Terrand J; Mlih M; Gracia C; Foppolo S; Martin S; Bruban V; Ji J; Velot E; Herz J; Boucher P
J Biol Chem; 2011 May; 286(19):16775-82. PubMed ID: 21454706
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor β-receptor, transforming growth factor β type I receptor, and CD44 protein modulate each other's signaling and stability.
Porsch H; Mehić M; Olofsson B; Heldin P; Heldin CH
J Biol Chem; 2014 Jul; 289(28):19747-57. PubMed ID: 24860093
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.
Davis FM; Rateri DL; Balakrishnan A; Howatt DA; Strickland DK; Muratoglu SC; Haggerty CM; Fornwalt BK; Cassis LA; Daugherty A
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):155-62. PubMed ID: 25395615
[TBL] [Abstract][Full Text] [Related]
19. TGFβ acts through PDGFRβ to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression.
Maity S; Das F; Kasinath BS; Ghosh-Choudhury N; Ghosh Choudhury G
J Biol Chem; 2020 Oct; 295(42):14262-14278. PubMed ID: 32732288
[TBL] [Abstract][Full Text] [Related]
20. PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL.
Getachew R; Ballinger ML; Burch ML; Reid JJ; Khachigian LM; Wight TN; Little PJ; Osman N
Endocrinology; 2010 Sep; 151(9):4356-67. PubMed ID: 20610572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
